BBGBloomberg·17hBusiness
score+0.60
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
Original
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
“Strong commercial performance highlighted with 'surge' and 'boosts,' framing price cuts and market success positively despite competitive pressures.”